Pandemic Puts Pressure on FDA on RWD
June 30, 2020
The COVID-19 pandemic has put increased pressure on the Food and Drug Administration’s real-world data initiatives.
According to a Pink Sheet report, the agency is set to hear from stakeholders on its data plans.
To read the report, click here.(Paid subscription required)